{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T18:44:12Z","timestamp":1790016252877,"version":"4.0.1"},"reference-count":66,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["HHSN2722011000005C"],"award-info":[{"award-number":["HHSN2722011000005C"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["HHSN272201000020I"],"award-info":[{"award-number":["HHSN272201000020I"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1016\/j.antiviral.2018.03.012","type":"journal-article","created":{"date-parts":[[2018,4,10]],"date-time":"2018-04-10T22:03:36Z","timestamp":1523397816000},"page":"158-165","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["BET bromodomain inhibitors show anti-papillomavirus activity in vitro and block CRPV wart growth in vivo"],"prefix":"10.1016","volume":"154","author":[{"given":"Mary A.","family":"Morse","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karla K.","family":"Balogh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah A.","family":"Brendle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colin A.","family":"Campbell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mao X.","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca C.","family":"Furze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isobel L.","family":"Harada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian D.","family":"Holyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Umesh","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2666-3326","authenticated-orcid":false,"given":"Rab K.","family":"Prinjha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"R\u00fcdiger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan T.","family":"Seal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason","family":"Witherington","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil D.","family":"Christensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.antiviral.2018.03.012_bib1","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/j.molcel.2006.11.002","article-title":"Structure of the papillomavirus DNA-tethering complex E2:Brd4 and a peptide that ablates HPV chromosomal association","volume":"24","author":"Abbate","year":"2006","journal-title":"Mol. Cell"},{"key":"10.1016\/j.antiviral.2018.03.012_bib2","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.antiviral.2009.10.019","article-title":"Epithelial raft cultures for investigations of virus growth, pathogenesis and efficacy of antiviral agents","volume":"85","author":"Andrei","year":"2010","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2018.03.012_bib3","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1189\/jlb.0312165","article-title":"BET bromodomain inhibition as a novel strategy for reactivation of HIV-1","volume":"92","author":"Banerjee","year":"2012","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.antiviral.2018.03.012_bib4","doi-asserted-by":"crossref","first-page":"4806","DOI":"10.1128\/JVI.79.8.4806-4818.2005","article-title":"The mitotic chromosome binding activity of the papillomavirus E2 protein correlates with interaction with the cellular chromosomal protein, Brd4","volume":"79","author":"Baxter","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2018.03.012_bib5","doi-asserted-by":"crossref","first-page":"4294","DOI":"10.1200\/JCO.2011.36.4596","article-title":"Human papillomavirus and rising oropharyngeal cancer incidence in the United States","volume":"29","author":"Chaturvedi","year":"2011","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.antiviral.2018.03.012_bib6","doi-asserted-by":"crossref","first-page":"98","DOI":"10.3410\/B1-98","article-title":"Brd4 engagement from chromatin targeting to transcriptional regulation: selective contact with acetylated histone H3 and H4","volume":"1","author":"Chiang","year":"2009","journal-title":"F1000 Biol. Rep."},{"key":"10.1016\/j.antiviral.2018.03.012_bib7","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1177\/095632020501600602","article-title":"Cottontail rabbit papillomavirus (CRPV) model system to test antiviral and immunotherapeutic strategies","volume":"16","author":"Christensen","year":"2005","journal-title":"Antivir. Chem. Chemother."},{"key":"10.1016\/j.antiviral.2018.03.012_bib8","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1128\/AAC.45.4.1201-1209.2001","article-title":"Combination treatment with intralesional cidofovir and viral-DNA vaccination cures large cottontail rabbit papillomavirus-induced papillomas and reduces recurrences","volume":"45","author":"Christensen","year":"2001","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2018.03.012_bib9","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0166-3542(00)00124-8","article-title":"In vivo anti-papillomavirus activity of nucleoside analogues including cidofovir on CRPV-induced rabbit papillomas","volume":"48","author":"Christensen","year":"2000","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2018.03.012_bib10","doi-asserted-by":"crossref","first-page":"3827","DOI":"10.1021\/jm200108t","article-title":"Discovery and characterization of small molecule inhibitors of the BET family bromodomains","volume":"54","author":"Chung","year":"2011","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.antiviral.2018.03.012_bib11","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/0166-3542(94)90067-1","article-title":"Interferons in human papillomavirus infections","volume":"24","author":"Cirelli","year":"1994","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2018.03.012_bib12","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.jviromet.2007.10.005","article-title":"Wounding prior to challenge substantially improves infectivity of cottontail rabbit papillomavirus and allows for standardization of infection","volume":"148","author":"Cladel","year":"2008","journal-title":"J. Virol. Methods"},{"key":"10.1016\/j.antiviral.2018.03.012_bib13","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0166-0934(03)00170-8","article-title":"Quantitative RT-PCR assay for HPV infection in cultured cells","volume":"111","author":"Culp","year":"2003","journal-title":"J. Virol. Methods"},{"key":"10.1016\/j.antiviral.2018.03.012_bib14","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1038\/nature10509","article-title":"Inhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukaemia","volume":"478","author":"Dawson","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.antiviral.2018.03.012_bib15","doi-asserted-by":"crossref","first-page":"10005","DOI":"10.1128\/JVI.75.20.10005-10013.2001","article-title":"Differentiation-dependent chromatin rearrangement coincides with activation of human papillomavirus type 31 late gene expression","volume":"75","author":"del Mar Pena","year":"2001","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2018.03.012_bib16","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1005366","article-title":"Papillomavirus-associated tumor formation critically depends on c-fos expression induced by viral protein E2 and bromodomain protein Brd4","volume":"12","author":"Delcuratolo","year":"2016","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.antiviral.2018.03.012_bib17","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/0042-6822(90)90401-C","article-title":"Detection of novel splicing patterns in a HPV16-containing keratinocyte cell line","volume":"178","author":"Doorbar","year":"1990","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2018.03.012_bib18","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1128\/jvi.21.3.1205-1209.1977","article-title":"Chromatin-like structures obtained after alkaline disruption of bovine and human papillomaviruses","volume":"21","author":"Favre","year":"1977","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2018.03.012_bib19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bcp.2015.12.005","article-title":"Bromodomains: structure, function and pharmacology of inhibition","volume":"106","author":"Ferri","year":"2016","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.antiviral.2018.03.012_bib20","doi-asserted-by":"crossref","first-page":"2692","DOI":"10.1016\/j.febslet.2012.04.045","article-title":"The bromodomain interaction module","volume":"586","author":"Filippakopoulos","year":"2012","journal-title":"FEBS Lett."},{"key":"10.1016\/j.antiviral.2018.03.012_bib21","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1038\/nature09504","article-title":"Selective inhibition of BET bromodomains","volume":"468","author":"Filippakopoulos","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.antiviral.2018.03.012_bib22","doi-asserted-by":"crossref","first-page":"4081","DOI":"10.1158\/0008-5472.CAN-09-3335","article-title":"In vitro progression of human papillomavirus 16 episome-associated cervical neoplasia displays fundamental similarities to integrant-associated carcinogenesis","volume":"70","author":"Gray","year":"2010","journal-title":"Cancer Res."},{"key":"10.1016\/j.antiviral.2018.03.012_bib23","doi-asserted-by":"crossref","first-page":"3228","DOI":"10.3390\/v6083228","article-title":"The cellular bromodomain protein Brd4 has multiple functions in E2-mediated papillomavirus transcription activation","volume":"6","author":"Helfer","year":"2014","journal-title":"Viruses"},{"key":"10.1016\/j.antiviral.2018.03.012_bib24","series-title":"Fields Virology 5th Edition","article-title":"Papillomaviruses","author":"Howley","year":"2007"},{"key":"10.1016\/j.antiviral.2018.03.012_bib25","doi-asserted-by":"crossref","first-page":"6453","DOI":"10.1128\/JVI.76.13.6453-6459.2002","article-title":"Intracutaneous DNA vaccination with the E8 gene of cottontail rabbit papillomavirus induces protective immunity against virus challenge in rabbits","volume":"76","author":"Hu","year":"2002","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2018.03.012_bib26","doi-asserted-by":"crossref","first-page":"2923","DOI":"10.1074\/jbc.M109113200","article-title":"Human papillomavirus type 16 E7 binds to E2F1 and activates E2F1-driven transcription in a retinoblastoma protein-independent manner","volume":"277","author":"Hwang","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.antiviral.2018.03.012_bib27","doi-asserted-by":"crossref","first-page":"3660","DOI":"10.1128\/JVI.80.7.3660-3665.2006","article-title":"Brd4 is involved in multiple processes of the bovine papillomavirus type 1 life cycle","volume":"80","author":"Ilves","year":"2006","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2018.03.012_bib28","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1002\/pmic.201400613","article-title":"A proteomic approach to discover and compare interacting partners of papillomavirus E2 proteins from diverse phylogenetic groups","volume":"15","author":"Jang","year":"2015","journal-title":"Proteomics"},{"key":"10.1016\/j.antiviral.2018.03.012_bib29","doi-asserted-by":"crossref","first-page":"2592","DOI":"10.1128\/JVI.02275-08","article-title":"Papillomavirus E2 proteins and the host BRD4 protein associate with transcriptionally active cellular chromatin","volume":"83","author":"Jang","year":"2009","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2018.03.012_bib30","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.molcel.2005.06.027","article-title":"The bromodomain protein Brd4 is a positive regulatory component of P-TEFb and stimulates RNA polymerase II-dependent transcription","volume":"19","author":"Jang","year":"2005","journal-title":"Mol. Cell"},{"key":"10.1016\/j.antiviral.2018.03.012_bib31","doi-asserted-by":"crossref","first-page":"11209","DOI":"10.1128\/JVI.76.22.11209-11215.2002","article-title":"A transactivator function of cottontail rabbit papillomavirus E2 is essential for tumor induction in rabbits","volume":"76","author":"Jeckel","year":"2002","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2018.03.012_bib32","doi-asserted-by":"crossref","first-page":"13284","DOI":"10.1074\/jbc.M116.751644","article-title":"Bromodomain and extraterminal inhibitors block the Epstein-Barr virus lytic cycle at two distinct steps","volume":"292","author":"Keck","year":"2017","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.antiviral.2018.03.012_bib33","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1111\/1523-1747.ep12614781","article-title":"Preclinical system for evaluating topical podofilox treatment of papillomas: dose-response and duration of growth prior to treatment","volume":"99","author":"Kreider","year":"1992","journal-title":"J. Investig. Dermatol."},{"key":"10.1016\/j.antiviral.2018.03.012_bib34","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1128\/jvi.61.2.590-593.1987","article-title":"Laboratory production in vivo of infectious human papillomavirus type 11","volume":"61","author":"Kreider","year":"1987","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2018.03.012_bib35","doi-asserted-by":"crossref","first-page":"2778","DOI":"10.1074\/jbc.M805835200","article-title":"Chromatin adaptor Brd4 modulates E2 transcription activity and protein stability","volume":"284","author":"Lee","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.antiviral.2018.03.012_bib36","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.cell.2012.06.045","article-title":"Small-molecule inhibition of BRDT for male contraception","volume":"150","author":"Matzuk","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.antiviral.2018.03.012_bib37","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.3390\/v5061374","article-title":"Current understanding of the role of the Brd4 protein in the papillomavirus lifecycle","volume":"5","author":"McBride","year":"2013","journal-title":"Viruses"},{"key":"10.1016\/j.antiviral.2018.03.012_bib38","doi-asserted-by":"crossref","first-page":"18411","DOI":"10.1016\/S0021-9258(18)55073-0","article-title":"The papillomavirus E2 regulatory proteins","volume":"266","author":"McBride","year":"1991","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.antiviral.2018.03.012_bib39","doi-asserted-by":"crossref","first-page":"9530","DOI":"10.1128\/JVI.01105-06","article-title":"Brd4 is required for e2-mediated transcriptional activation but not genome partitioning of all papillomaviruses","volume":"80","author":"McPhillips","year":"2006","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2018.03.012_bib40","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1002761","article-title":"Large scale genotype comparison of human papillomavirus E2-host interaction networks provides new insights for e2 molecular functions","volume":"8","author":"Muller","year":"2012","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.antiviral.2018.03.012_bib41","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1038\/nature09589","article-title":"Suppression of inflammation by a synthetic histone mimic","volume":"468","author":"Nicodeme","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.antiviral.2018.03.012_bib42","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1002334","article-title":"RNA polymerase II stalling promotes nucleosome occlusion and pTEFb recruitment to drive immortalization by Epstein-Barr virus","volume":"7","author":"Palermo","year":"2011","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.antiviral.2018.03.012_bib43","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/29.9.e45","article-title":"A new mathematical model for relative quantification in real-time RT\u2013PCR","volume":"29","author":"Pfaffl","year":"2001","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.antiviral.2018.03.012_bib44","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.tips.2011.12.002","article-title":"Place your BETs: the therapeutic potential of bromodomains","volume":"33","author":"Prinjha","year":"2012","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.antiviral.2018.03.012_bib45","first-page":"642","article-title":"Randomized, comparative trial on the sustained efficacy of topical imiquimod 5% cream versus conventional ablative methods in external anogenital warts","volume":"16","author":"Schofer","year":"2006","journal-title":"Eur. J. Dermatol. EJD"},{"key":"10.1016\/j.antiviral.2018.03.012_bib46","doi-asserted-by":"crossref","first-page":"9612","DOI":"10.1128\/JVI.00447-07","article-title":"Brd4-independent transcriptional repression function of the papillomavirus e2 proteins","volume":"81","author":"Schweiger","year":"2007","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2018.03.012_bib47","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.virol.2006.08.035","article-title":"Amino acid substitutions that specifically impair the transcriptional activity of papillomavirus E2 affect binding to the long isoform of Brd4","volume":"358","author":"Senechal","year":"2007","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2018.03.012_bib48","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/j.molcel.2014.05.016","article-title":"The mechanisms behind the therapeutic activity of BET bromodomain inhibition","volume":"54","author":"Shi","year":"2014","journal-title":"Mol. Cell"},{"key":"10.1016\/j.antiviral.2018.03.012_bib49","doi-asserted-by":"crossref","first-page":"247","DOI":"10.3851\/IMP3133","article-title":"Ranpirnase eradicates human papillomavirus in cultured cells and heals anogenital warts in a Phase I study","volume":"22","author":"Squiquera","year":"2017","journal-title":"Antivir. Ther."},{"key":"10.1016\/j.antiviral.2018.03.012_bib50","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1099\/vir.0.039677-0","article-title":"Genital human papillomavirus infections: current and prospective therapies","volume":"93","author":"Stanley","year":"2012","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.antiviral.2018.03.012_bib51","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1002\/ijc.2910430422","article-title":"Properties of a non-tumorigenic human cervical keratinocyte cell line","volume":"43","author":"Stanley","year":"1989","journal-title":"Int. J. Cancer"},{"issue":"Suppl. 5","key":"10.1016\/j.antiviral.2018.03.012_bib52","doi-asserted-by":"crossref","first-page":"F71","DOI":"10.1016\/j.vaccine.2012.05.091","article-title":"Therapy of human papillomavirus-related disease","volume":"30","author":"Stern","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.antiviral.2018.03.012_bib53","first-page":"5","article-title":"Anogenital human papillomavirus and the problem of persistence","volume":"8","author":"Syrjanen","year":"1998","journal-title":"Eur. J. Dermatol."},{"key":"10.1016\/j.antiviral.2018.03.012_bib54","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.cbpa.2016.05.028","article-title":"Clinical progress and pharmacology of small molecule bromodomain inhibitors","volume":"33","author":"Theodoulou","year":"2016","journal-title":"Curr. Opin. Chem. Biol."},{"key":"10.1016\/j.antiviral.2018.03.012_bib55","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.biocel.2006.09.006","article-title":"HPV-18 E7 conjugates to c-Myc and mediates its transcriptional activity","volume":"39","author":"Wang","year":"2007","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.antiviral.2018.03.012_bib56","doi-asserted-by":"crossref","first-page":"537","DOI":"10.2741\/3632","article-title":"WHAT do viruses BET on?","volume":"15","author":"Weidner-Glunde","year":"2010","journal-title":"Front. Biosci. Landmark. Ed."},{"key":"10.1016\/j.antiviral.2018.03.012_bib57","doi-asserted-by":"crossref","first-page":"2777","DOI":"10.1128\/AAC.00103-09","article-title":"GS-9191 is a novel topical prodrug of the nucleotide analog 9-(2-phosphonylmethoxyethyl)guanine with antiproliferative activity and possible utility in the treatment of human papillomavirus lesions","volume":"53","author":"Wolfgang","year":"2009","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2018.03.012_bib58","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.virol.2007.12.011","article-title":"Regulation of human papillomavirus type 31 gene expression during the differentiation-dependent life cycle through histone modifications and transcription factor binding","volume":"374","author":"Wooldridge","year":"2008","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2018.03.012_bib59","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1016\/j.celrep.2016.07.001","article-title":"BRD4 phosphorylation regulates HPV e2-mediated viral transcription, origin replication, and cellular MMP-9 expression","volume":"16","author":"Wu","year":"2016","journal-title":"Cell Rep."},{"key":"10.1016\/j.antiviral.2018.03.012_bib60","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1101\/gad.1448206","article-title":"Brd4 links chromatin targeting to HPV transcriptional silencing","volume":"20","author":"Wu","year":"2006","journal-title":"Genes. Dev."},{"key":"10.1016\/j.antiviral.2018.03.012_bib61","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1128\/JVI.01647-09","article-title":"Abrogation of the Brd4-positive transcription elongation factor B complex by papillomavirus E2 protein contributes to viral oncogene repression","volume":"84","author":"Yan","year":"2010","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2018.03.012_bib62","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.molcel.2005.06.029","article-title":"Recruitment of P-TEFb for stimulation of transcriptional elongation by the bromodomain protein Brd4","volume":"19","author":"Yang","year":"2005","journal-title":"Mol. Cell"},{"key":"10.1016\/j.antiviral.2018.03.012_bib63","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.bbagrm.2009.09.009","article-title":"Papillomavirus interaction with cellular chromatin","volume":"1799","author":"You","year":"2010","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.antiviral.2018.03.012_bib64","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/S0092-8674(04)00402-7","article-title":"Interaction of the bovine papillomavirus E2 protein with Brd4 tethers the viral DNA to host mitotic chromosomes","volume":"117","author":"You","year":"2004","journal-title":"Cell"},{"key":"10.1016\/j.antiviral.2018.03.012_bib65","doi-asserted-by":"crossref","first-page":"14956","DOI":"10.1128\/JVI.79.23.14956-14961.2005","article-title":"Inhibition of E2 binding to Brd4 enhances viral genome loss and phenotypic reversion of bovine papillomavirus-transformed cells","volume":"79","author":"You","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2018.03.012_bib66","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/j.celrep.2012.09.008","article-title":"Reactivation of latent HIV-1 by inhibition of BRD4","volume":"2","author":"Zhu","year":"2012","journal-title":"Cell Rep."}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354217306332?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354217306332?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T12:29:19Z","timestamp":1759062559000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354217306332"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6]]},"references-count":66,"alternative-id":["S0166354217306332"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2018.03.012","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2018,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"BET bromodomain inhibitors show anti-papillomavirus activity in vitro and block CRPV wart growth in vivo","name":"articletitle","label":"Article Title"},{"value":"Antiviral Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.antiviral.2018.03.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}